Biggest News Aggregation in the World
📰 Eric Roeland News

Page 2 - Eric Roeland News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Eric Roeland. Real-time updates on events, politics, business and more.

Jaguar Health, Inc.: Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting

(0) SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the highlights of the abstract regarding patient outcomes associated with cancer-related diarrhea ("CRD") by Napo Pharmaceuticals, Inc. ("Napo"), Jaguars wholly owned subsidiary, and Napos collaborators that has been accepted for poster presentation at the American Society of Clinical Oncology (ASCO ®) Annual Meeting, which will be held virtually from June 4-8, 2021...
United States University Of Texas Lee Schwartzberg Eric Roeland Pabloc Okhuysen Peter Hodge

Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting

Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting ACCESSWIRE 20 May 2021, 22:43 GMT+10 SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar or the Company) today announced the highlights of the abstract regarding patient outcomes associated with cancer-related diarrhea (CRD) by Napo Pharmaceuticals, Inc. (Napo), Jaguars wholly owned subsidiary, and Napos collabora...
United States University Of Texas Lee Schwartzberg Eric Roeland Pabloc Okhuysen Peter Hodge

Jaguar Health, Inc.: Jaguar Health and Napo Pharmaceuticals Announce Title of Abstract Regarding Patient Outcomes Associated with Cancer Therapy-Related Diarrhea Accepted for Poster Presentation at the American Society of Clinical Oncology 2021 Annual Mee

(0) SAN FRANCISCO, CA / ACCESSWIRE / April 29, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced the title of the abstract regarding patient outcomes associated with cancer therapy-related diarrhea ("CTD") by Napo Pharmaceuticals, Inc. ("Napo"), Jaguars wholly owned subsidiary, and Napos collaborators that has been accepted for poster presentation at the American Society of Clinical Oncology (ASCO ®) Annual Meeting, which will be held virtually from June 4-8, 2021. The title of the acce...
United States University Of Texas Lee Schwartzberg Eric Roeland Pabloc Okhuysen Peter Hodge

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science